Passion and compassion are the two engines that drive "venture philanthropist" Paul Tudor Jones II, founder, chairman and CEO of The Tudor Group. Passion fuels his vocation as a hedge fund trader extraordinaire. As of this month, Jones has amassed a personal fortune of around $3.7 billion, according to Forbes. Compassion clearly energizes his avocation, helping homeless children and the poor. Paul Tudor Jones is the founder of Robin Hood, a charitable organization formed in 1988 to target poverty in New York City. Its board of directors is peopled with a number of Guru billionaire investors. In his 2011 speech at the Robin Hood Heroes Breakfast, Jones outlined the various kinds of poverty, the worst being a poverty of opportunity Americans are facing. Last year, Robin Hood invested $132 million in 210 poverty-fighting programs.
The Tudor Group portfolio currently lists 779 stocks, 289 of them new, with a total value of $1.33 billion and a quarter-over-quarter turnover of 58%. The portfolio top three sector weights healthcare at 23.9%, ETF, options, preferred at 22.2% and industrials at 11.2%. Paul Tudor Jones’s 12-month average return is 35.13%; he’s averaged 6% since inception.
Here’s a look at the top four high-impact reductions and sells in The Tudor Group portfolio as of the second quarter of 2013.
Financial Select Sector SPDR ETF (XLF, Financial): Reduced
Impact to Portfolio: - 4.26%
Up 29% over 12 months, Financial Select Sector SPDR ETF has a market cap of $9.78 billion; its shares were traded at around $20.14. The dividend is 1.60%.
The Financial Select Sector SPDR ETF is an exchange traded fund.
Historical share pricing:
Guru Action: As of June 30, 2013, Paul Tudor Jones reduced his position by 52.56%, selling 3,077,000 shares at an average price of $19.08, for a loss of 5.6%. The current share price is $20.14, with a change from average up 6%. His current shares remaining are 2,777,000.
In a five-year trading history, Paul Tudor Jones has averaged a gain of 24% on 5,854,000 shares bought at an average price of $16.24 per share. On shares sold, he has averaged a gain of 6% on 3,077,000 shares sold at an average price of $19.08 per share.
Pfizer Inc. (PFE, Financial): Reduced
Impact to Portfolio: - 3.57%
Up 16% over 12 months, Pfizer Inc. has a market cap of $190.67 billion; its shares were traded at around $28.88. The P/B ratio is 2.40. The dividend yield is 3.26%.
Founded in 1849, Pfizer Inc. is a global pharmaceutical firm which develops and produces medicines and vaccines used in the fields of immunology, inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain.
Historical share pricing, revenue and net income:
Guru Action: As of June 30, 2013, Paul Tudor Jones reduced his position by 89.18%, selling 1,629,350 shares at an average price of $29.12, for a loss of 1.1%. The current share price is $28.80, with a change from average down 1%. His current shares remaining are 197,700.
Paul Tudor Jones has averaged a gained of 5% on 1,827,050 shares bought at an average price of $27.34 per share. On shares sold, he has averaged a loss of 1% on 1,629,350 shares sold at an average price of $29.12 per share.
Illinois Tool Works Inc. (ITW, Financial): Sold Out
Impact to Portfolio: - 3.2%
Up 28% over 12 months, Illinois Tool Works Inc. has a market cap of $34.14 billion; its shares were traded at around $78.29. The P/B ratio is 3.30. The dividend yield is 2.00%.
Incorporated in 1915, Illinois Tool Works Inc. is a multinational manufacturer of a range of industrial products and equipment with operations in 58 countries. These businesses are internally reported as 40 operating segments to senior management.
Historical share pricing, revenue and net income:
Guru Action: As of June 30, 2013, Paul Tudor Jones sold out his position, selling 7,500 shares at an average price of $66.88, for a 14% gain. The current share price is $76.23, with a change from average up 14%.
In 10 quarters of holding, Paul Tudor Jones had double-digit gains all the way.
His gains topped out at 73.1% in the third quarter of 2010.
Covidien PLC (COV, Financial): Sold Out
Impact to Portfolio: - 2%
Up 16% over 12 months, Covidien PLC has a market cap of $28.8 billion; its shares were traded at around $62.27. The P/B ratio is 3.00. The dividend yield is 1.66%.
Covidien PLC is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Its products are found in almost every hospital in the United States.
Historical share pricing, revenue and net income:
Guru Action: As of June 30, 2013, Paul Tudor Jones sold out his position selling 380,400 shares at an average price of $59.39, for a gain of 5.4%. The current share price is $62.61, with a change from average up 5%.
This is another remarkable five-year trading history with gains all the way.
Here is the complete portfolio of Paul Tudor Jones.
Be sure to read:
1. Paul Tudor Jones's Undervalued Stocks
2. Paul Tudor Jones's Top Growth Companies
3. Paul Tudor Jones's High Yield stocks
4. Stocks that Paul Tudor Jones keeps buying
If you are not yet a Premium Member, try a 7-day Free Trial.
GuruFocus Real Time Picks reports the stock purchases and sales that Gurus have made within the prior 2 weeks. The report time lag can be as short as 2 days after the date of the transaction. This feature is for Premium Members only.
Check out the GuruFocus special feature 52-week low screener to find the stocks hitting new lows but are still held by top investor Gurus and Insiders.
The Tudor Group portfolio currently lists 779 stocks, 289 of them new, with a total value of $1.33 billion and a quarter-over-quarter turnover of 58%. The portfolio top three sector weights healthcare at 23.9%, ETF, options, preferred at 22.2% and industrials at 11.2%. Paul Tudor Jones’s 12-month average return is 35.13%; he’s averaged 6% since inception.
Here’s a look at the top four high-impact reductions and sells in The Tudor Group portfolio as of the second quarter of 2013.
Financial Select Sector SPDR ETF (XLF, Financial): Reduced
Impact to Portfolio: - 4.26%
Up 29% over 12 months, Financial Select Sector SPDR ETF has a market cap of $9.78 billion; its shares were traded at around $20.14. The dividend is 1.60%.
The Financial Select Sector SPDR ETF is an exchange traded fund.
Historical share pricing:
Guru Action: As of June 30, 2013, Paul Tudor Jones reduced his position by 52.56%, selling 3,077,000 shares at an average price of $19.08, for a loss of 5.6%. The current share price is $20.14, with a change from average up 6%. His current shares remaining are 2,777,000.
In a five-year trading history, Paul Tudor Jones has averaged a gain of 24% on 5,854,000 shares bought at an average price of $16.24 per share. On shares sold, he has averaged a gain of 6% on 3,077,000 shares sold at an average price of $19.08 per share.
Pfizer Inc. (PFE, Financial): Reduced
Impact to Portfolio: - 3.57%
Up 16% over 12 months, Pfizer Inc. has a market cap of $190.67 billion; its shares were traded at around $28.88. The P/B ratio is 2.40. The dividend yield is 3.26%.
Founded in 1849, Pfizer Inc. is a global pharmaceutical firm which develops and produces medicines and vaccines used in the fields of immunology, inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain.
Historical share pricing, revenue and net income:
Guru Action: As of June 30, 2013, Paul Tudor Jones reduced his position by 89.18%, selling 1,629,350 shares at an average price of $29.12, for a loss of 1.1%. The current share price is $28.80, with a change from average down 1%. His current shares remaining are 197,700.
Paul Tudor Jones has averaged a gained of 5% on 1,827,050 shares bought at an average price of $27.34 per share. On shares sold, he has averaged a loss of 1% on 1,629,350 shares sold at an average price of $29.12 per share.
Illinois Tool Works Inc. (ITW, Financial): Sold Out
Impact to Portfolio: - 3.2%
Up 28% over 12 months, Illinois Tool Works Inc. has a market cap of $34.14 billion; its shares were traded at around $78.29. The P/B ratio is 3.30. The dividend yield is 2.00%.
Incorporated in 1915, Illinois Tool Works Inc. is a multinational manufacturer of a range of industrial products and equipment with operations in 58 countries. These businesses are internally reported as 40 operating segments to senior management.
Historical share pricing, revenue and net income:
Guru Action: As of June 30, 2013, Paul Tudor Jones sold out his position, selling 7,500 shares at an average price of $66.88, for a 14% gain. The current share price is $76.23, with a change from average up 14%.
In 10 quarters of holding, Paul Tudor Jones had double-digit gains all the way.
His gains topped out at 73.1% in the third quarter of 2010.
Covidien PLC (COV, Financial): Sold Out
Impact to Portfolio: - 2%
Up 16% over 12 months, Covidien PLC has a market cap of $28.8 billion; its shares were traded at around $62.27. The P/B ratio is 3.00. The dividend yield is 1.66%.
Covidien PLC is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Its products are found in almost every hospital in the United States.
Historical share pricing, revenue and net income:
Guru Action: As of June 30, 2013, Paul Tudor Jones sold out his position selling 380,400 shares at an average price of $59.39, for a gain of 5.4%. The current share price is $62.61, with a change from average up 5%.
This is another remarkable five-year trading history with gains all the way.
Here is the complete portfolio of Paul Tudor Jones.
Be sure to read:
1. Paul Tudor Jones's Undervalued Stocks
2. Paul Tudor Jones's Top Growth Companies
3. Paul Tudor Jones's High Yield stocks
4. Stocks that Paul Tudor Jones keeps buying
If you are not yet a Premium Member, try a 7-day Free Trial.
GuruFocus Real Time Picks reports the stock purchases and sales that Gurus have made within the prior 2 weeks. The report time lag can be as short as 2 days after the date of the transaction. This feature is for Premium Members only.
Check out the GuruFocus special feature 52-week low screener to find the stocks hitting new lows but are still held by top investor Gurus and Insiders.
